$SEPN 3 SEC Filings

Filed On	Filing
03 Sep 2026	Form 3: Patni Rajiv, Chief Medical Officer No securities owned
15 Jan 2026	Form 3: Wilson Mark Andrew, Chief Legal Officer No securities owned
29 Sep 2025	Form 3: Gottesdiener Keith Michael, Director No securities owned
07 Jan 2025	Form 3: Labrucherie Gil M, Chief Financial Officer No securities owned
24 Oct 2024	Form 3: Bhatt Elizabeth, Chief Operating Officer Holds 174,209 shares of Common Stock
24 Oct 2024	Form 3: Xiao Ran, Interim CFO Holds 58,069 shares of Common Stock
24 Oct 2024	Form 3: Kim Jae B., Chief Medical Officer
24 Oct 2024	Form 3: Klein Uwe, SVP, Biological Sciences Holds 104,525 shares of Common Stock
24 Oct 2024	Form 3: Tong Jeffrey K, Director
24 Oct 2024	Form 3: Shaikhly Samira, Chief People Officer
24 Oct 2024	Form 3: Third Rock Ventures V, L.p., 10% owner and 5 others Holds 1,054,318 shares of Common Stock
24 Oct 2024	Form 3: Ra Capital MANAGEMENT, L.p., Director and 4 others
24 Oct 2024	Form 3: Finer Jeffrey, Director Holds 754,907 shares of Common Stock
24 Oct 2024	Form 3: Ezekowitz Alan, Director Holds 17,420 shares of Common Stock
24 Oct 2024	Form 3: Sharp Shalini, Director
24 Oct 2024	Form 3: Simson Jake, Director
24 Oct 2024	Form 3: Coulie Bernard, Director
24 Oct 2024	Form 3: Bassan Abraham, Director
24 Oct 2024	Form 3: Long Daniel D., SVP, Drug Discovery Holds 92,911 shares of Common Stock

Comments